	Extrarenal TFE3-Rearranged Renal Cell Carcinoma: Diagnostic Challenges in an Uncommon Scalp Localization. Turk Patoloji Derg Tazi I, Allaoui M, El-Ochi MR, Mustapha A, Damiri A, Elktaibi A, Essaoudi A, Chahdi H, Oukabli M. PMID: 42836579 [PubMed - as supplied by publisher]
	The safety and efficacy of metformin on metabolic syndrome parameters in prostate cancer patients receiving androgen deprivation therapy: A systematic review and meta-analysis. Arab J Urol Alharran AM, Alsaid MA, Hussain AA, Aladwani FA, Alaradi H. PMID: 42836214 [PubMed]
	Shared decision-making experiences regarding urinary diversion among Chinese patients with muscle-invasive bladder cancer: A qualitative study. Asia Pac J Oncol Nurs Zhu K, Zhang Y, Wang Y, Chen L, Qiao W, Tan M, Liu J, Li K, Hou S. PMID: 42835880 [PubMed]
	Minimum ADC outperforms PSA and PSA density for predicting ISUP grade group in prostate cancer: a retrospective study of 192 patients undergoing radical prostatectomy. Front Oncol Skrobisz K, Bernard W, Bromirski R, Nowak K, Gli, Po, Pie. PMID: 42835434 [PubMed]
	Early insulin combined with metformin therapy and long-term risks of cardiovascular disease, kidney disease, and cancer in newly diagnosed type 2 diabetes: a real-world cohort study in China. Front Endocrinol (Lausanne) Yan L, Luo Q, Wang J, Zhang S, Xu R, Lv M, Su P, Zhang S, Ji X, Zhu G, Xue F. PMID: 42835393 [PubMed - indexed for MEDLINE]
	Exploring cheminformatics tools to combat prostate cancer: diagnostics, therapeutics, and mechanistic studies. In Silico Pharmacol Igwe S, Ehi-Eromosele CO, Udofia IA, Oloba-Whenu OA. PMID: 42835226 [PubMed]
	MRI-based habitat radiomics analysis for predicting clinically significant prostate cancer: a retrospective dual-center study. Front Oncol Chen Z, Ye Y, Peng Y, Gong Z, Liu Z, Xiang X, Liao Y, Gong L. PMID: 42835136 [PubMed]
	Practical deep learning solutions for prostate cancer segmentation and implementation in radiotherapy planning. Phys Eng Sci Med Hizam DA, Saad M, Ung NM, Muaadz A, Salleh FM, Tan LK. PMID: 42834307 [PubMed - as supplied by publisher]
	Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.04.013. Eur Urol Stabile A, Quarta L, Scilipoti P, Dehò F, Briganti A, Montorsi F. PMID: 42833933 [PubMed - as supplied by publisher]
	Efficacy and Safety of Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Non-BRCA Mutation Subgroup of Patients with Metastatic Castration-resistant Prostate Cancer in the PROpel Trial. Eur Urol Oncol Mehra N, Clarke NW, Armstrong AJ, Oya M, Shore N, Procopio G, Guedes JD, Arslan C, Brown E, Joung JY, Sugimoto M, Choi YD, Castellano D, Ürün Y, Hosius C, McGuinness D, Degboe A, Saad F. PMID: 42833926 [PubMed - as supplied by publisher]
	Two-stage high-frequency ultrasonic characterization of ex vivo renal tumor microstructure. Ultrasound Med Biol Zuluaga L, Gleed AD, Bamby J, Okhawere KE, Levieddin J, Ucpinar B, Ucpinar BA, Hoerig C, Mamou J, Badani KK. PMID: 42833906 [PubMed - as supplied by publisher]
	Testosterone breakthrough and outcomes during intensified therapy in metastatic hormone-sensitive prostate cancer: the ARASENS and LATITUDE trials. BJU Int Xiao X, Ni X, Zhao Y, Li X, Wang S, Wang H, Ye D, Wu J, Zhu Y. PMID: 42833883 [PubMed - as supplied by publisher]
	Integrated computational framework for drug repurposing in metastatic prostate cancer using transcriptomic meta-analysis, machine learning, and molecular modeling. Comput Biol Chem Rafiee J, Arabi Baygi ST, Aghaee-Bakhtiari SH. PMID: 42833027 [PubMed - as supplied by publisher]
	Explainable Machine Learning-Based Prediction of Progression-Free Survival in Prostate Cancer: Retrospective Cohort Study. JMIR Cancer Tun HM, Naing L, Malik OA, Abdullah MS, Ta T, Rahman HA. PMID: 42832781 [PubMed - indexed for MEDLINE]
	Leveraging Artificial Intelligence to Monitor Patients With Prostate Cancer in a Retrospective Cohort of Radiation Oncology Clinic Patients. Clin J Oncol Nurs Boyajian RN, Hagen M, Bagchi S, Mahatma S, Kowtoniuk A, Trinh QD, Kumar T, Nguyen PL. PMID: 42832322 [PubMed - indexed for MEDLINE]
	Full-Field Optical Coherence Tomography for Immediate Analysis of Prostate Biopsy Cores: A New Step toward Real-Time Cancer Diagnosis. Ann Surg Oncol Anract J, Chen W, Duquesne I, Larnaudie L, Diamand R, Sibony M, Barry Delongchamps N. PMID: 42832144 [PubMed - as supplied by publisher]
	Targeted pelvic lymph node dissection using magnetic resonance imaging - ultrasonography fusion technique and indocyanine green injection in robot-assisted radical prostatectomy. J Robot Surg Yamada Y, Kimura N, Hakozaki Y, Nakamura M, Sugano K, Sugimoto K, Kakutani S, Miyakawa J, Kamei J, Niimi A, Taguchi S, Kume H. PMID: 42832079 [PubMed - indexed for MEDLINE]
	The effect of ureteral stenting on the risk of metachronous upper tract urothelial carcinoma in patients with bladder tumors involving the ureteral orifice. World J Urol Pyrgidis N, Engelmann P, Puhr-Westerheide D, Ebner B, Kidess M, Semmler M, Keller P, Stief C, Schulz GB, Volz Y. PMID: 42832054 [PubMed - indexed for MEDLINE]
	Partial vs. whole-gland salvage hifu after radiotherapy failure: oncological and functional outcomes. World J Urol Maillard C, Mebroukine S, Haaser T, Pasticier G, Robert G, Bladou F. PMID: 42831949 [PubMed - indexed for MEDLINE]
	A Clinical Insight into Von Hippel-Lindau Syndrome: Diagnostic Challenges. Prague Med Rep Rosado GAC, da Cunha AC, Duarte ML, de Abreu VMG. PMID: 42831607 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 181956

Page 1 of 9098



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy